Table 1 Distribution of subsequent treatments after treatment with immunotherapies
Distribution | Source | |
|---|---|---|
Chemotherapy | ||
Pemetrexed | 60% | Expert opinion |
Gemcitabine | 10% | |
Carboplatin | 45% | |
Cisplatin | 20% | |
Paclitaxel | 5% | |
Docetaxel | 10% | |
Vinorelbine | 30% | |
Targeted therapy | ||
Bevacizumab | 5% | Expert opinion |
Nintedanib | 5% | |